CAS 80370-57-6 Ceftiofur Hydrochloride API Veterinary Raw Material

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Drum/Bag
Delivery Time: Negotiation
Payment Terms: L/C, D/A, D/P, T/T
Supply Ability: Negotiation
Cas No: 80370-57-6 Ec No: 1308068-626-2
Name: Ceftiofur Synonyms: 3-[(2-FURYLCARBONYL)THIO]METHYL]-7-[2-(2-AMINO-4-THIAZOLYL)-2-(METHOXYIMINOACETAMIDO)-3-CEPHEM-4-CARBOXYLIC ACID
Molecular Formula: C19H17N5O7S3 Molecular Weight: 523.56
Density: 1.81±0.1 G/cm3
High Light:

CAS no 80370-57-6

,

ceftiofur api

,

ceftiofur veterinary

Ceftiofur;CAS 80370-57-6;API; Veterinary

Specification:

 

Name Ceftiofur
Synonyms 3-[(2-FURYLCARBONYL)THIO]METHYL]-7-[2-(2-AMINO-4-THIAZOLYL)-2-(METHOXYIMINOACETAMIDO)-3-CEPHEM-4-CARBOXYLIC ACID
Molecular Formula C19H17N5O7S3
Molecular Weight 523.56
CAS Registry Number 80370-57-6
EINECS Number 1308068-626-2
Density 1.81±0.1 g/cm3

 

Product Description:

 

Ceftiofur is the veterinary-exclusive third-generation cephalosporins successfully developed by United States in the 1980s. It entered into market for the first time in the United States. Owing to their excellent antibacterial activity and pharmacokinetic characteristics, it has been officially approved by the United States, Canada, Japan and some European countries for being use in the treatment of respiratory therapy of beef cattle, dairy cattle, horses, pigs, and sheep. Its appearance is white to light yellow powder. It is insoluble in water, slightly soluble in acetone, and almost insoluble in ethanol.

 

Product Use:

 

Animal-specific antibiotic medicines used for treating Gram-positive and Gram-negative bacteria and Mycoplasma infection.
Veterinary (original powder)

 

 

CAS 80370-57-6 Ceftiofur Hydrochloride  API Veterinary Raw Material 0

 

Product Catalogue:

Number Cas Name
1 71751-41-2 Avermectin
2 54965-21-8 Albendazole
3 80370-57-6 Ceftiofur
4 2971-90-6 Clopidol
5 148-01-6 Dinitolmide
6 101831-37-2 Diclazuril
7 76639-94-6 Florfenicol
8 43210-67-9 Fenbendazol
9 70288-86-7 Ivermectin
10 103055-07-8 Lufenuron
11 113507-06-5 Moxidectin
12 84878-61-5 Maduramycin ammonium
13 23696-28-8 Olaquindox
14 121-19-7 Roxarsone
15 21736-83-4 Spectinomycin Hydrochloride
16 15318-45-3 Thiamphenicol
17 52628-58-7 Thiamphenicol Palmitate
18 108050-54-0 Tilmicosin

 

About us

 

 

Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.

Contact Details
ray

Phone Number : +8619967305667

WhatsApp : +8613588430486